Differential Notch and TGFβ signaling in primary colorectal tumors and their corresponding metastases

Cellular Oncology

Volumn 30, Issue 1, 2008, Pages 1-11

  Veenendaal, Liesbeth M ^a   Kranenburg, Onno ^a   Smakman, Niels ^a   Klomp, Annemarie ^a   Borel Rinkes, Inne H M ^a   Van Diest, Paul J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Colorectal; Epithelial mesenchymal transition; HES1; KRAS; Metastasis; Notch; Vimentin

Indexed keywords

BETA CATENIN; FIBRONECTIN; NOTCH RECEPTOR; SMAD2 PROTEIN; TRANSCRIPTION FACTOR HES 1; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN; VIMENTIN; WNT PROTEIN; CADHERIN; KRAS PROTEIN, HUMAN; ONCOPROTEIN; RAS PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRAIN METASTASIS; CARCINOGENESIS; CELL DIFFERENTIATION; COLON MUCOSA; COLORECTAL TUMOR; CONTROLLED STUDY; FEMALE; GENE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; ONCOGENE K RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; BRAIN TUMOR; LIVER TUMOR; LUNG TUMOR; LYMPH NODE METASTASIS; METABOLISM; MIDDLE AGED; PATHOLOGY; SIGNAL TRANSDUCTION; TISSUE MICROARRAY;

ADULT; AGED; BRAIN NEOPLASMS; CADHERINS; COLORECTAL NEOPLASMS; FEMALE; FIBRONECTINS; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION; TISSUE ARRAY ANALYSIS; TRANSFORMING GROWTH FACTOR BETA; VIMENTIN; WNT PROTEINS;

EID: 38549116499     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. F. Radtke and H. Clevers, Self-renewal and cancer of the gut: two sides of a coin, Science 307 (2005), 1904-1909.
2. T.P. Pretlow and T.G. Pretlow, Mutant KRAS in aberrant crypt foci (ACF): initiation of colorectal cancer?, Biochim. Biophys. Acta 1756 (2005), 83-96.
3. P. Castagnola and W. Giaretti, Mutant KRAS, chromosomal instability and prognosis in colorectal cancer, Biochim. Biophys. Acta 1756 (2005), 115-125.
4. T.E. Buffart, J. Coffa, M.A. Hermsen, B. Carvalho, J.R. van der Sijp, B. Ylstra, G. Pals, J.P. Schouten and G.A. Meijer, DNA copy number changes at 8q11-24 in metastasized colorectal cancer, Cell Oncol. 27 (2005), 57-65.
5. B.M. Ghadimi, M. Grade, C. Monkemeyer, B. Kulle, J. Gaedcke, B. Gunawan, C. Langer, T. Liersch and H. Becker, Distinct chromosomal profiles in metastasizing and non-metastasizing colorectal carcinomas, Cell Oncol. 28 (2006), 273-281.
6. M. Grade, P. Hormann, S. Becker, A.B. Hummon, D. Wangsa, S. Varma, R. Simon, T. Liersch, H. Becker, M.J. Difilippantonio, B.M. Ghadimi and T. Ried, Gene expression profiling reveals a massive, aneuploidy-dependent transcriptional deregulation and distinct differences between lymph node-negative and lymph node-positive colon carcinomas, Cancer Res. 67 (2007), 41-56.
7. J.P. Thiery, Epithelial-mesenchymal transitions in tumour progression, Nat. Rev. Cancer 2 (2002), 442-454.
8. J.P. Thiery, Epithelial-mesenchymal transitions in development and pathologies, Curr. Opin. Cell Biol. 15 (2003), 740-746.
9. M.A. Huber, N. Kraut and H. Beug, Molecular requirements for epithelial-mesenchymal transition during tumor progression, Curr. Opin. Cell Biol. 17 (2005), 548-558.
10. P.M. Steinert and D.R. Roop, Molecular and cellular biology of intermediate filaments, Annu. Rev. Biochem. 57 (1988), 593-625.
11. J.P. Thiery, Epithelial-mesenchymal transitions in tumour progression, Nat. Rev. Cancer 2 (2002), 442-454.
12. F.C. Ramaekers, D. Haag, A. Kant, O. Moesker, P.H. Jap and G.P. Vooijs, Coexpression of keratin- and vimentin-type intermediate filaments in human metastatic carcinoma cells, Proc. Natl. Acad. Sci. U.S.A 80 (1983), 2618-2622.
13. C. Gilles, M. Polette, J. Piette, A.C. Delvigne, E.W. Thompson, J.M. Foidart and P. Birembaut, Vimentin expression in cervical carcinomas: association with invasive and migratory potential, J. Pathol. 180 (1996), 175-180.
14. M.J. Hendrix, E.A. Seftor, Y.W. Chu, K.T. Trevor and R.E. Seftor, Role of intermediate filaments in migration, invasion and metastasis, Cancer Met. Rev. 15 (1996), 507-525.
15. P.J. van Diest, No consent should be needed for using leftover body material for scientific purposes, BMJ 325 (2002), 648-651.
16. E.H. Gort, A.J. Groot, T.L. Derks van de Ven, P. van der Groep, I. Verlaan, T. van Laar, P.J. van Diest, E. van der Wall and A. Shvarts, Hypoxia-inducible factor-1alpha expression requires PI 3-kinase activity and correlates with Akt1 phosphorylation in invasive breast carcinomas, Oncogene 25 (2006), 6123-6127.
17. T.P. Pretlow and T.G. Pretlow, Mutant KRAS in aberrant crypt foci (ACF): initiation of colorectal cancer?, Biochim. Biophys. Acta 1756 (2005), 83-96.
18. N. Smakman, I.H.M. Borel Rinkes, E.E. Voest and O. Kranenburg, Control of colorectal metastasis formation by K-Ras, Biochim. Biophys. Acta 1756 (2005), 103-114.
19. M.A. Huber, N. Kraut and H. Beug, Molecular requirements for epithelial-mesenchymal transition during tumor progression, Curr. Opin. Cell Biol. 17 (2005), 548-558.
20. R. Fodde and T. Brabletz, Wnt/beta-catenin signaling in cancer stemness and malignant behavior, Curr. Opin. Cell Biol. 19 (2007), 150-158.
21. P.W. Derksen, X. Liu, F. Saridin, H. van der Gulden, J. Zevenhoven, B. Evers, J.R. van Beijnum, A.W. Griffioen, J. Vink, P. Krimpenfort, J.L. Peterse, R.D. Cardiff, A. Berns and J. Jonkers, Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis, Cancer Cell 10 (2006), 437-449.
22. W. Xie, D.L. Rimm, Y. Lin, W.J. Shih and M. Reiss, Loss of Smad signaling in human colorectal cancer is associated with advanced disease and poor prognosis, Cancer J. 9 (2003), 302-312.
23. J.H. van Es, M.E. van Gijn, O. Riccio, M. van den Born, M. Vooijs, H. Begthel, M. Cozijnsen, S. Robine, D.J. Winton, F. Radtke and H. Clevers, Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells, Nature 435 (2005), 959-963.
24. F. Al Mulla, W.N. Keith, I.R. Pickford, J.J. Going and G.D. Birnie, Comparative genomic hybridization analysis of primary colorectal carcinomas and their synchronous metastases, genes chromosomes, Cancer 24 (1999), 306-314.
25. I. Albanese, A.G. Scibetta, M. Migliavacca, A. Russo, V. Bazan, R.M. Tomasino, P. Colomba, M. Tagliavia and M. La Farina, Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations, Biochem. Biophys. Res. Commun. 325 (2004), 784-791.
26. A. D'Arrigo, C. Belluco, A. Ambrosi, M. Digito, G. Esposito, A. Bertola, M. Fabris, V. Nofrate, E. Mammano, A. Leon, D. Nitti and M. Lise, Metastatic transcriptional pattern revealed by gene expression profiling in primary colorectal carcinoma, Int. J. Cancer 115 (2005), 256-262.
27. C.B. Diep, M.R. Teixeira, L. Thorstensen, J.N. Wiig, M. Eknaes, J.M. Nesland, K.E. Giercksky, B. Johansson and R.A. Lothe, Genome characteristics of primary carcinomas, local recurrences, carcinomatoses, and liver metastases from colorectal cancer patients, Mol. Cancer 3 (2004), 6.
28. A. Koehler, F. Bataille, C. Schmid, P. Ruemmele, A. Waldeck, H. Blaszyk, A. Hartmann, F. Hofstaedter and W. Dietmaier, Gene expression profiling of colorectal cancer and metastases divides tumours according to their clinicopathological stage, J. Pathol. 204 (2004), 65-74.
29. R. Yanagawa, Y. Furukawa, T. Tsunoda, O. Kitahara, M. Kameyama, K. Murata, O. Ishikawa and Y. Nakamura, Genome-wide screening of genes showing altered expression in liver metastases of human colorectal cancers by cDNA microarray, Neoplasia 3 (2001), 395-401.
30. E. Janda, K. Lehmann, I. Killisch, M. Jechlinger, M. Herzig, J. Downward, H. Beug and S. Grunert, Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways, J. Cell Biol. 156 (2002), 299-313.
31. J. Gotzmann, M. Mikula, A. Eger, R. Schulte-Hermann, R. Foisner, H. Beug and W. Mikulits, Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis, Mutat. Res. 566 (2004), 9-20.
32. D. Tarin, E.W. Thompson and D.F. Newgreen, The fallacy of epithelial mesenchymal transition in neoplasia, Cancer Res. 65 (2005), 5996-6000.
33. E.W. Thompson, D.F. Newgreen and D. Tarin, Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition?, Cancer Res. 65 (2005), 5991-5995.
34. L.A. Timmerman, J. Grego-Bessa, A. Raya, E. Bertran, J.M. Perez-Pomares, J. Diez, S. Aranda, S. Palomo, F. McCormick, J.C. Izpisua-Belmonte and J.L. de la Pompa, Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation, Genes Dev. 18 (2004), 99-115.
35. J. Grego-Bessa, J. Diez, L. Timmerman and J.L. de la Pompa, Notch and epithelial-mesenchyme transition in development and tumor progression: another turn of the screw, Cell Cycle 3 (2004), 718-721.
36. J.H. van Es and H. Clevers, Notch and Wnt inhibitors as potential new drugs for intestinal neoplastic disease, Trends Mol. Med. 11 (2005), 496-502.